Kvantify launches physics-based binding affinity-software for drug discovery with high accuracy and unprecedented speed

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Kvantify

More Like This

PR Newswire associated0

Kvantify Qrunch - Unlocking Quantum Computing for Chemical and Biological Innovation

PR Newswire associated0

Tetra Pharm Technologies and Kvantify Announce Partnership to Accelerate the Discovery of Novel Drug Candidates Targeting the Endocannabinoid System

PR Newswire associated0

Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery

PR Newswire associated0

New CAS BioFinder Discovery Platform empowers drug discovery scientists to reveal insights, drive innovation, and save time

ACCESSWIRE logo

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery

Business Wire logo

IonQ Speeds Quantum-Accelerated Drug Development Application With AstraZeneca, AWS, and NVIDIA

Business Wire logo

NanoTemper Technologies Launches Human Fc Labeling Kit, Accelerating Biologics Affinity Screening Workflows

PR Newswire associated0

Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA